Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01885299 · ClinicalTrials.gov registry record
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
A clinical trial of Neoplasms and Trigeminal Neuralgia, sponsored by The Radiosurgery Society.
- Recruiting
- Registry status
- 50,000
- Enrollment target
- 13
- Study locations
NCT01885299: Recruiting study of Neoplasms and Trigeminal Neuralgia, sponsored by The Radiosurgery Society.
NCT01885299 is a study of Neoplasms and Trigeminal Neuralgia that is actively recruiting participants, run by The Radiosurgery Society. The registered enrollment target is 50,000 participants, above the 1,305-participant average among 158 other Neoplasms trials with a reported enrollment target (3731% higher). The trial reports 13 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01885299, a study of Neoplasms and Trigeminal Neuralgia, is actively recruiting participants, sponsored by The Radiosurgery Society.
- RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
- 13
- Study locations
Study Summary
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)
Primary Outcome
Survival from time of treatment to death
Conditions Studied
Interventions
- RADIATION SRS/SBRT
Study Locations (13)
New Jersey
- AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute - Egg Harbor
- Riverview Medical Center - Red Bank
- NJ Cyberknife at Community Medical Center - Toms River
Pennsylvania
- Geisinger Health System - Danville
- Philadelphia CyberKnife - Philadelphia
- Pottstown Memorial Medical Center - Pottstown
Colorado
- Penrose Cancer Center - Colorado Springs
Florida
- Sylvester Comprehensive Cancer Center, University of Miami - Miami
Georgia
- Southeast Georgia Health System - Brunswick
Michigan
- Henry Ford Health System - Detroit
New York
- Montefiore Medical Center - The Bronx
Tennessee
- Cyberknife at Erlanger - Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2012-03 |
| Est. Completion | 2030-12 |
What NCT01885299 shows while recruiting
NCT01885299 is an observational study that tracks outcomes without assigning an intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,305-participant average among 158 other Neoplasms trials with a reported enrollment target (3731% higher).
The record links to 3 conditions, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which SRS/SBRT is the first listed.
NCT01885299 lists 13 locations in 9 states (New Jersey, Pennsylvania, Colorado).
Frequently Asked Questions
What is clinical trial NCT01885299 about?
NCT01885299 is a clinical study titled "RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT". The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with...
What is the current status of trial NCT01885299?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2012-03. Estimated completion is 2030-12.
What conditions does trial NCT01885299 study?
This clinical trial studies the following conditions: Neoplasms, Trigeminal Neuralgia, Arteriovenous Malformation of Central Nervous System.
What interventions are being tested in trial NCT01885299?
The interventions under investigation include: SRS/SBRT (RADIATION).
Who is sponsoring clinical trial NCT01885299?
This trial is sponsored by The Radiosurgery Society, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01885299 being conducted?
This trial has 13 study locations across Colorado, Florida, Georgia, Michigan, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01885299's enrollment target sits among peer trials
50,000 2nd of 158 the highest of 158 other Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Resilience in East Asian Immigrants for Advance Care Planning Discussions
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
- NCT05497518 · 50,000 participants
The KidneyCARE (Community Access to Research Equity) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia